Sporadic nontoxic goiter

Textbook of Endocrine Surgery

Volumn , Issue , 2005, Pages 24-33

  Al Fehaily, Maha ^a   Clark, Orlo H ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 38149022312     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0139-7.50008-9     Document Type: Chapter

References (108)

1. Greenspan FS Medical treatment of nodular goiter. Endocrine Surgery of the Thyroid and Parathyroid Glands 1985, 35. CV Mosby, St. Louis. O.H. Clark (Ed.).
2. Samuels MH Evaluation and treatment of sporadic nontoxic goiter-some answers and more questions. J Clin Endocrinol Metab 2001, 86:994.
3. Rojeski MT, Gharib H Nodular thyroid disease: Evaluation and management. N Engl J Med 1985, 313:428.
4. Gharib H Thyroid incidentalomas: Management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997, 126:226.
5. Bonnema SJ, Bennedbaek FN, Ladenson PW, Hegedus L Management of the nontoxic multinodular goiter: A North American survey. J Clin Endocrinol Metab 2002, 87:112.
6. - symporter. J Clin Endocrinol Metab 1999, 84:3750.
7. Bignell GR, Canzian F, Shayeghi M, et al. Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial non-medullary thyroid cancer. Am J Hum Genet 1997, 61:1123.
8. Greig WR, Boyle JA, Duncan A, et al. Genetic and non-genetic factors in simple goitre formation: Evidence from a twin study. Q J Med 1967, 36:175.
9. Brix TH, Kyvik KO, Hegedus L Major role of genes in the etiology of simple goiter in females: A population-based twin study. J Clin Endocrinol Metab 1999, 84:3071.
10. Rousseau-Merck MF, Misrahi M, Loosfelt H, et al. Assignment of the human thyroid-stimulating hormone receptor (TSHR) gene to chromosome 14q31. Genomics 1990, 8:233.
11. Gabriel EM, Bergert ER, Grant CS, et al. Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter. J Clin Endocrinol Metab 1999, 84:3328.
12. Vulsma T, Gons MH, de Vijlder JJM Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 1989, 321:13.
13. Bray GA Increased sensitivity of the thyroid in iodine-depleted rats to the goitrogenic effects of thyrotropin. J Clin Invest 1968, 47:1640.
14. Glinoer D, Lemone M Goiter and pregnancy: A new insight into an old problem. Thyroid 1992, 2:65.
15. Clark OH, Lambert WR, Cavalieri RR, et al. Compensatory thyroid hypertrophy after hemithyroidectomy in rats. Endocrinology 1976, 99:988.
16. Clark OH, Lambert WR, Cavalieri RR, et al. Effect of iodide on compensatory goiter in rats following hemithyroidectomy. Surg Forum 1975, 26:182.
17. Young RL, Harvey WC, Mazzaferri EL, et al. Thyroid-stimulating hormone levels in idiopathic euthyroid goiter. J Clin Endocrinol Metab 1975, 41:21.
18. Grubeck-Loebenstein B, Buchan G, Sadeghi R, et al. Transforming growth factor beta regulates thyroid growth: Role in the pathogenesis of nontoxic goiter. J Clin Invest 1989, 83:764.
19. Namba H, Rubin SA, Fagin JA Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Mol Endocrinol 1990, 4:1474.
20. Meier CA Nontoxic goiter. Surgery of the Thyroid and Parathyroid Glands 2003, 61. WB Saunders, Philadelphia. G.W. Randolph (Ed.).
21. Gerber H, Burgi U, Peter HJ Pathogenesis of non-toxic goitre. Oxford Textbook of Endocrinology and Diabetes 2002, 553. Oxford University Press, New York. J.A.H. Wass, S.M. Shalet (Eds.).
22. Derwahl M, Studer H Nodular goiter and goiter nodules: Where iodine deficiency falls short of explaining the facts. Exp Clin Endocrinol Diabetes 2001, 109:250.
23. Derwahl M, Studer H Multinodular goitre: "Much more to it than simply iodine deficiency.". Baillieres Best Pract Res Clin Endocrinol Metab 2000, 14:577.
24. Kim H, Piao Z, Park C, et al. Clinical significance of clonality in thyroid nodules. Br J Surg 1998, 85:1125.
25. Kopp P, Kimura ET, Aeschimann S, et al. Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters. J Clin Endocrinol Metab 1994, 79:134.
26. Tassi V, Di Cerbo A, Porcellini A, et al. Screening of thyrotropin receptor mutations by fine-needle aspiration biopsy in autonomous-functioning thyroid nodules in multinodular goiters. Thyroid 1999, 9:353.
27. Hermus AR, Huysmans DA Pathogenesis of nontoxic diffuse and nodular goiter. The Thyroid: A Fundamental and Clinical Text 2000, 861. Lippincott William & Wilkins, Philadelphia. L.E. Braverman, R.D. Utiger (Eds.).
28. Berghout A, Wiersinga WM, Smits NJ, Touber JL Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med 1990, 89:602.
29. Elte JW, Bussemaker JK, Haak A The natural history of euthyroid multinodular goitre. Postgrad Med J 1990, 66:186.
30. Wiener JD, de Vries AA On the natural history of Plummer's disease. Clin Nucl Med 1979, 4:181.
31. Tuttle RM, Lemar H, Burch HB Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 1998, 8:377.
32. Greenspan FS Radiation exposure and thyroid cancer. JAMA 1977, 237:2089.
33. Modan B, Ron E, Werner A Thyroid cancer following scalp irradiation. Radiology 1977, 123:741.
34. Balter M Chernobyl's thyroid cancer toll. Science 1995, 270:1758.
35. Clark OH Thyroid nodules and cancer risk: Surgical management. Thyroid Cancer: A Comprehensive Guide to Clinical Management 2000, 49. Humana, Totowa, NJ. L. Wartofsky (Ed.).
36. Hegedus L, Bonnema SJ, Bennedbaek FN Management of simple nodular goiter: Current status and future perspectives. Endocr Rev 2003, 24:102.
37. Marqusee E, Benson CB, Frates MC, et al. Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 2000, 133:696.
38. Tollin SR, Mery GM, Jelveh N, et al. The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter. Thyroid 2000, 10:235.
39. McCall A, Jarosz H, Lawrence AM, Paloyan E The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters. Surgery 1986, 100:1128.
40. Franklyn JA, Daykin J, Young J, et al. Fine-needle aspiration cytology in diffuse or multinodular goitre compared with solitary thyroid nodules. BMJ 1993, 307:240.
41. Hermus AR, Huysmans DA Treatment of benign nodular thyroid disease. N Engl J Med 1998, 338:1438.
42. Bisi H, Ruggeri GB, Longatto Filho A, et al. Neoplastic and non-neoplastic thyroid lesions in autopsy material: Historical review of six decades in Sao Paulo, Brazil. Tumori 1998, 84:499.
43. Pelizzo MR, Piotto A, Rubello D, et al. High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease. Tumori 1990, 76:255.
44. Park SH, Suh EH, Chi JG A histopathologic study on 1,095 surgically resected thyroid specimens. Jpn J Clin Oncol 1988, 18:297.
45. Mitselou A, Vougiouklakis T, Peschos D, et al. Occult thyroid carcinoma: A study of 160 autopsy cases. The First Report for the Region of Epirus-Greece. Anticancer Res 2002, 22:427.
46. Yamamoto Y, Maeda T, Izumi K, Otsuka H Occult papillary carcinoma of the thyroid: A study of 408 autopsy cases. Cancer 1990, 65:1173.
47. Lang W, Borrusch H, Bauer L Occult carcinomas of the thyroid: Evaluation of 1,020 sequential autopsies. Am J Clin Pathol 1988, 90:72.
48. Komorowski RA, Hanson GA Occult thyroid pathology in the young adult: An autopsy study of 138 patients without clinical thyroid disease. Hum Pathol 1988, 19:689.
49. Harach HR, Franssila KO, Wasenius VM Occult papillary carcinoma of the thyroid: A "normal" finding in Finland-a systematic autopsy study. Cancer 1985, 56:531.
50. Chong PY Thyroid carcinomas in Singapore autopsies. Pathology 1994, 26:20.
51. Yamashita H Occult microcancer and clinical cancer. Hyoid Cancer: Diagnosis and Treatment 2000, 105. Quality Medical, St. Louis. O.H. Clark, S. Noguchi (Eds.).
52. Hagag P, Strauss S, Weiss M Role of ultrasound-guided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules. Thyroid 1998, 8:989.
53. Khurana KK, Richards VI, Chopra PS, et al. The role of ultrasonography-guided fine-needle aspiration biopsy in the management of nonpalpable and palpable thyroid nodules. Thyroid 1998, 8:511.
54. Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: Predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002, 87:1941.
55. Lupoli G, Vitale G, Caraglia M, et al. Familial papillary thyroid micro-carcinoma: A new clinical entity. Lancet 1999, 353:637.
56. Nakhjavani M, Gharib H Diffuse nontoxic and multinodular goiter. CurrTher Endocrinol Metab 1997, 6:109.
57. Peccin S, de Castro JA, Furlanetto TW, et al. Ultrasonography: Is it useful in the diagnosis of cancer in thyroid nodules?. J Endocrinol Invest 2002, 25:39.
58. Rios Zambudio A, Rodriguez Gonzalez JM, Carrasco Prats M, et al. Superior vena cava syndrome caused by multinodular goiter. Rev Clin Esp 2000, 200:208.
59. Anders HJ Compression syndromes caused by substernal goitres. Postgrad Med J 1998, 74:327.
60. Anders H, Keller C Pemberton's maneuver-a clinical test for latent superior vena cava syndrome caused by a substernal mass. Eur J Med Res 1997, 2:488.
61. Auwaerter PG The Pemberton and Maroni signs. Ann Intern Med 1997, 126:916.
62. Lassaletta Atienza L, Melchor Diaz MA, Gavilanes Plasencia J, et al. [Thyroid nodules: Factors suggestive of malignancy]. Acta Otorrinolaringol Esp 1997, 48:220.
63. Cerise EJ, Randall S, Ochsner A Carcinoma of the thyroid and nontoxic nodular goiter. Surgery 1952, 31:552.
64. Niccoli P, Wion-Barbot N, Caron P, et al. Interest of routine measurement of serum calcitonin: Study in a large series of thyroidectomized patients. The French Medullary Study Group. J Clin Endocrinol Metab 1997, 82:338.
65. Netterville JL, Coleman SC, Smith JC, et al. Management of substernal goiter. Laryngoscope 1998, 108:1611.
66. Jennings A Evaluation of substernal goiters using computed tomography and MR imaging. Endocrinol Metab Clin North Am 2001, 30:401.
67. Wesche MF, Tiel VB, Lips P, et al. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 2001, 86:998.
68. Hurley DL, Gharib H Evaluation and management of multinodular goiter. Otolaryngol Clin North Am 1996, 29:527.
69. Arici C, Dertsiz L, Altunbas H, et al. Operative management of substernal goiter: Analysis of 52 patients. Int Surg 2001, 86:220.
70. Gharib H, Mazzaferri EL Thyroxine-suppressive therapy in patients with nodular thyroid disease. Ann Intern Med 1998, 128:386.
71. Ross DS Thyroid hormone suppressive therapy of sporadic nontoxic goiter. Thyroid 1992, 2:263.
72. Lima N, Knobel M, Cavaliere H, et al. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 1997, 7:691.
73. Glueck CJ, Streicher P Cardiovascular and medical ramifications of treatment of subclinical hypothyroidism. Curr Atheroscler Rep 2003, 5:73.
74. Burmeister LA, Flores A Subclinical thyrotoxicosis and the heart. Thyroid 2002, 12:495.
75. Mercuro G, Panzuto MG, Bina A, et al. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: Effect of individual dose tailoring. J Clin Endocrinol Metab 2000, 85:159.
76. Shapiro LE, Sievert R, Ong L, et al. Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of l-thyroxine. J Clin Endocrinol Metab 1997, 82:2592.
77. Perk M, O'Neill BJ The effect of thyroid hormone therapy on angiographic coronary artery disease progression. Can J Cardiol 1997, 13:273.
78. Sijanovic S, Karner I Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone. Medscape Women's Health 2001, 6:3.
79. Jodar E, Martinez-Diaz-Guerra G, Azriel S, Hawkins F Bone mineral density in male patients with l-thyroxine suppressive therapy and Graves' disease. Calcif Tissue Int 2001, 69:84.
80. Nuzzo V, Lupoli G, Esposito Del, Puente A, et al. Bone mineral density in premenopausal women receiving levothyroxine suppressive therapy. Gynecol Endocrinol 1998, 12:333.
81. Knudsen N, Faber J, Sierbaek-Nielsen A, et al. Thyroid hormone treatment aiming at reduced, but not suppressed, serum thyroid-stimulating hormone levels in nontoxic goiter: Effects on bone metabolism amongst premenopausal women. J Intern Med 1998, 243:149.
82. Bonnema SJ, Knudsen DU, Bertelsen H, et al. Does radioiodine therapy have an equal effect on substernal and cervical goiter volumes? Evaluation by magnetic resonance imaging. Thyroid 2002, 12:313.
83. Huysmans D, Hermus A, Edelbroek M, et al. Radioiodine for nontoxic multinodular goiter. Thyroid 1997, 7:235.
84. Huysmans DA, Buijs WC, van de Ven MT, et al. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters. J Nucl Med 1996, 37:2072.
85. 131I therapy of toxic and non-toxic goiters. Q J Nucl Med 1999, 43:291.
86. Maurer AH, Charkes ND Radioiodine treatment for nontoxic multinodular goiter. J Nucl Med 1999, 40:1313.
87. 131I therapy of multinodular goitre. Clin Endocrinol (Oxf) 1994, 41:715.
88. 131I treatment in patients with nontoxic goiter. J Clin Endocrinol Metab 1997, 82:2926.
89. Hall P, Lundell G, Holm LE Mortality in patients treated for hyperthyroidism with iodine 131. Acta Endocrinol (Copenh) 1993, 128:230.
90. Franklyn JA, Maisonneuve P, Sheppard M, et al. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: A population-based cohort study. Lancet 1999, 353:2111.
91. Franklyn JA, Maisonneuve P, Sheppard MC, et al. Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med 1998, 338:712.
92. Tezelman S, Grossman RF, Siperstein AE, Clark OH Radioiodine-associated thyroid cancers. World J Surg 1994, 18:522.
93. Nervi M, Iacconi P, Spinelli C, et al. Thyroid carcinoma in intrathoracic goiter. Langenbecks Arch Surg 1998, 383:337.
94. Torre G, Borgonovo G, Amato A, et al. Surgical management of substernal goiter: Analysis of 237 patients. Am Surg 1995, 61:826.
95. Rojdmark J, Jarhult J High long-term recurrence rate after subtotal thyroidectomy for nodular goitre. Eur J Surg 1995, 161:725.
96. Cohen-Kerem R, Schachter P, Sheinfeld M, et al. Multinodular goiter: The surgical procedure of choice. Otolaryngol Head Neck Surg 2000, 122:848.
97. Thomusch O, Machens A, Sekulla C, et al. Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: Prospective multicenter study in Germany. World J Surg 2000, 24:1335.
98. Wilson DB, Staren ED, Prinz RA Thyroid reoperations: Indications and risks. Am Surg 1998, 64:674. discussion, 678.
99. Makeieff M, Rubinstein P, Youssef B, et al. Repeat surgery for thyroid nodules (excluding cancer and hyperthyroidism). Ann Chir 1998, 52:970.
100. Shen W, Kebebew E, Duh QY, Clark OH Substernal goiter. Arch Surg 2004, 139:656.
101. Mattioli FP, Torre GC, Borgonovo G, et al. Surgical treatment of multinodular goiter. Ann Ital Chir 1996, 67:341.
102. Gough IR, Wilkinson D Total thyroidectomy for management of thyroid disease. World J Surg 2000, 24:962.
103. Delbridge L, Guinea AI, Reeve TS Total thyroidectomy for bilateral benign multinodular goiter: Effect of changing practice. Arch Surg 1999, 134:1389.
104. Marchesi M, Biffoni M, Tartaglia F, et al. Total versus subtotal thyroidectomy in the management of multinodular goiter. Int Surg 1998, 83:202.
105. Vagenakis AG, Wang CA, Burger A, et al. Iodide-induced thyrotoxicosis in Boston. N Engl J Med 1972, 287:523.
106. Robbins J, Schneider AB Thyroid cancer following exposure to radioactive iodine. Rev Endocr Metab Disord 2000, 1:197.
107. Hahn K, Schnell-Inderst P, Grosche B, Holm LE Thyroid cancer after diagnostic administration of iodine 131 in childhood. Radiat Res 2001, 156:61.
108. Hall P, Holm LE Late consequences of radioiodine for diagnosis and therapy in Sweden. Thyroid 1997, 7:205.